Fatal toxic epidermal necrolysis associated with use of terconazole vaginal suppository.
Searles
G E
GE
Division of Dermatology and Cutaneous Sciences, University of Alberta, Canada.
Tredget
E E
EE
Lin
A N
AN
D000282:Administration, Intravaginal; D000328:Adult; D000935:Antifungal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D009102:Multiple Organ Failure; D013262:Stevens-Johnson Syndrome / Q000209:etiology*; D014230:Triazoles / Q000009:adverse effects* / Q000627:therapeutic use
D000935:Antifungal Agents; D014230:Triazoles; C037815:terconazole